News Releases

Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial

October 15, 2024

Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development

October 7, 2024

Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial

September 30, 2024

Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine

September 24, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference

September 18, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium

September 3, 2024

Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference

August 26, 2024

Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting

July 29, 2024

Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy

July 23, 2024

Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology

July 17, 2024

Latest News & Events

May 11, 2026

Anixa Biosciences Reports Updated Positive Survival Observations from Ongoing Phase 1 Trial of Lira-cel Ovarian Cancer CAR-T Therapy

Read More...

May 1, 2026

Anixa Biosciences Interview to Air on the RedChip Small Stocks, Big Money™ Show on Bloomberg TV

Read More...

Apr 29, 2026

Anixa Biosciences Announces Issuance of Mexican Patent Covering Breast Cancer Vaccine Technology

Read More...